My fishing guide, Shiloh Patterson, vividly remembers the first time he hooked a king salmon back in 1997. The fight lasted ...
The Securities and Exchange Commission recently issued a notice regarding intended exemptive relief (the “Notice”) that would permit an ...
Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action in the U.S. District Court for the Southern District of New York alleging violations ...
Discover why Global Medical REIT is now a Strong Buy. Learn about solid AFFO growth, strong dividends, and GMRE’s compelling ...
For public companies looking to raise capital relatively quickly and at a lower cost, equity lines of credit (ELOCs) and at-the-market ...
Detailed price information for Oxford Lane Capital (OXLC-Q) from The Globe and Mail including charting and trades.
Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...
Planned U.S. launch of Anaphylm™ in the first quarter of 2026, if approved by the FDA Advanced Anaphylm regulatory activities in Canada and the ...
Sunshine Residential's $100K gift was the 2nd largest to Hobbs' inauguration fund. Giving Sunshine a raise after the donation ...
The Healthy @Reader's Digest on MSN
Here’s How Long Most People Stay on a Weight-Loss Drug, Say Obesity Medicine Doctors
How long would you need to jab yourself...and contend with the cost? Two MDs specializing in weight loss and endocrinology share how it works.
In October 2025, encouraging initial clinical data from the Phase 1 trial of ZW191 (NCT06555744), an ADC targeting FR , were presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer ...
Experts say the Colorado River shows no sign of recovery. The Republic asked water providers how they would survive shortages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results